Ping An Biomedical Co Shares Outstanding History (PASW)
Ping An Biomedical Co reported 20.5M shares outstanding at the end of fiscal 2025.
View full Ping An Biomedical Co company overviewPing An Biomedical Co annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 20.5M | 2.5M | +13.89% |
| 2024 | 2024-09-30 | 18.0M | −2.5M | −12.20% |
| 2023 | 2023-09-30 | 20.5M | 0 | 0.00% |
| 2022 | 2022-09-30 | 20.5M | — | — |
Ping An Biomedical Co quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-09-30 | 20.5M | 2.5M | +13.89% |
| Q2 2025 | 2025-03-31 | 18.0M | — | — |
| Q4 2024 | 2024-09-30 | 18.0M | — | — |
Ping An Biomedical Co shares outstanding trends
Between the periods ended 2022-09-30 and 2025-09-30, Ping An Biomedical Co's shares outstanding moved from 20.5M to 20.5M, a change of 0. The latest reported quarter, Q4 2025, shows 20.5M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ping An Biomedical Co source filings ↗